Alzamend Neuro (ALZN) Change in Cash (2020 - 2026)

Alzamend Neuro has disclosed Change in Cash across 7 years of filings, most recently posting -$2.0 million for Q2 2026.

• In Q2 2026, Change in Cash fell 439.1% year-over-year to -$2.0 million; the TTM figure through Apr 2026 stood at -$3.2 million (down 190.63% YoY), while the FY2026 annual figure was -$3.2 million, down 190.63% from the prior year.
• Change in Cash came in at -$2.0 million for Q2 2026 at Alzamend Neuro, down from -$1.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $2.9 million in Q4 2024 to a low of -$3.4 million in Q3 2023.
• Average Change in Cash over 5 years is -$714555.7, with a median of -$1.3 million recorded in 2023.
• Year-over-year, Change in Cash sank 5210.54% in 2022 and jumped 533.74% in 2025.
• Over 5 years, Change in Cash stood at -$2.3 million in 2022, then surged by 36.21% to -$1.5 million in 2023, then jumped by 293.88% to $2.9 million in 2024, then slumped by 140.41% to -$1.2 million in 2025, then slumped by 70.94% to -$2.0 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$2.0 million in Q2 2026, -$1.7 million in Q1 2026, and -$1.2 million in Q4 2025.